DEA Form 225 - New Application for Registration
This form is for new applicants. Any person who does not currently possess a DEA registration to conduct business with controlled substances in the following categories may access the application form. The categories of applicant who can apply using this form are manufacturers, distributors, researchers, canine handlers, analytical laboratories, importers, and exporters.
Complete DEA Form 225 Online (If possible, you are encouraged to use the online forms system to apply for your registration.)
Note: Researchers with Schedule I drugs only must submit DEA 225 PDF application and the protocol found in 21 CFR 1301.18. You cannot apply online for your initial application.
Download DEA Form 225 (PDF) to apply via U.S. Postal Service.
Before you enter the form, you may wish to print the instruction pages (recommended) which will assist in completing the form. After completing the form, print, sign and mail to DEA.
Information must be typed or printed in the blocks provided to help reduce data entry errors. A physical address is required in address line 1; a post office box or continuation of address may be entered in address line 2. Fee exempt applicant must list the address of the fee exempt institution. Applicant must enter a valid social security number (SSN), or a tax identification number (TIN) if applying as a business entity.
Debt collection information is mandatory pursuant to the Debt Collection Improvement Act of 1996.
Indicate only one. Each type of business activity requires a separate application. You are required to register as a "manufacturer" if you manufacture a controlled substance or list 1 chemical and then distribute it.
Applicant should check all schedules to be handled. However, applicant must still comply with state requirements; federal registration does not overrule state restrictions. Check the order form box only if you intend to purchase or to transfer schedule 1 and 2 controlled substances. Order forms will be mailed to the registered address following issuance of a Certificate of Registration.
Mark the chemical/controlled substance schedule(s) handled in each manufacturing stage listed.
Report all chemical/drug codes as required for your business activity. Controlled sustances manufacturers and importers must obtain a separate chemical registration if they handle chemicals other than an FDA-approved drug product containing 1225, 8112, or 8113.
Federal registration by DEA is based upon the applicant's compliance with applicable state and local laws. Applicant should contact the local state licensing authority prior to completing this application. If your state requires a license, provide that number on this application.
Applicant must answer all four questions for the application to be accepted for processing. If you answer "Yes" to a question, provide an explanation in the space provided. If you answer "Yes" to several questions, then you must provide a separate explanation describing the date, location, nature, and result of each incident. If additional space is required, you may attach a separate page.
Exemption from payment of application fee is limited to federal, state or local government official or institution. The applicant's superior or agency officer must certify exempt status. The signature, authority title, and telephone number of the certifying official (other than the applicant) must be provided. The address of the fee exempt institution must appear in Section 1.
Indicate the desired method of payment. Make checks payable to "Drug Enforcement Administration". Third-party checks or checks drawn on foreign banks will not be accepted. FEES ARE NON-REFUNDABLE.
Applicant MUST sign in this section or application will be returned. Card holder signature in section 7 does not fulfill this requirement.
Researcher or canine handler must attach 3 copies of protocol, including curriculum vitae, to conduct research with schedule 1 controlled substances. For clinical investigations, researcher must first submit to FDA a "Notice of Claimed Investigational Exemption for New Drug (IND)". See DEA web site or CFR 1301.18 for details.
Authorization to Convert Your Check:
If you send us a check to make your payment, your check will be converted into an electronic fund transfer. "Electronic fund transfer" is the term used to refer to the process in which we electronically instruct your financial institution to transfer funds from your account to our account, rather than processing your check. By sending your completed, signed check to us, you authorize us to copy your check and to use the account information from your check to make an electronic fund transfer from your account for the same amount as the check. If the electronic fund transfer cannot be processed for technical reasons, you authorize us to process the copy of your check.
The electronic funds transfer from your account will usually occur within 24 hours, which is faster than a check is normally processed. Therefore, make sure there are sufficient funds available in your checking account when you send us your check. If the electronic funds transfer cannot be completed because of insufficient funds, we may try to make the transfer up to two more times.
The electronic fund transfer from your account will be on the account statement you receive from your financial institution. However, the transfer may be in a different place on your statement than the place where your checks normally appear. For example, it may appear under "other withdrawals" or "other transactions". You will not receive your original check back from your financial institution. For security reasons, we will destroy your original check, but we will keep a copy of the check for record-keeping purposes.
You should contact your financial institution immediately if you believe that the electronic fund transfer reported on your account statement was not properly authorized or is otherwise incorrect. Consumers have protections under Federal law called the Electronic Fund Transfer Act for an unauthorized or incorrect electronic fund transfer.
No registration will be issued unless a completed application form has been received (21 CFR 1301.13).
In accordance with the Paperwork Reduction Act of 1995, no person is required to respond to a collection of information unless it displays a valid OMB control number. The OMB number for this collection is 1117-0012. Public reporting burden for this collection of information is estimated to average 12 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the information.
The Debt Collection Improvements Act of 1996 (31 U.S.C. §7701) requires that you furnish your Taxpayer Identification Number (TIN) or Social Security Number (SSN) on this application. This number is required for debt collection procedures if your fee is not collectible.
PRIVACY ACT NOTICE: Providing information other than your SSN or TIN is voluntary; however, failure to furnish it will preclude processing of the application. The authorities for collection of this information are §§302 and 303 of the Controlled Substances Act (CSA) (21 U.S.C. §§822 and 823). The principle purpose for which the information will be used is to register applicants pursuant to the CSA. The information may be disclosed to other Federal law enforcement and regulatory agencies for law enforcement and regulatory purposes, State and local law enforcement and regulatory agencies for law enforcement and regulatory purposes, and person registered under the CSA for the purpose of verifying registration. For further guidance regarding how your information may be used or disclosed, and a complete list of the routine uses of this collection, please see the DEA System of Records Notice "Controlled Substances Act Registration Records" (DEA-005), 52 FR 47208, December 11, 1987, as modified.
Listed below are examples of schedules 1-5 and List 1 codes. Check all drug and chemical codes you handle as required.
If you bulk manufacture a substance, check the bulk column after the applicable drug code.
For more information, see our website at www.deadiversion.usdoj.gov, 21 CFR 1308, or call 1-800-882-9539.
|Canine Handler||must mark schedule 1|
|Exporter||must mark all schedule 1-5|
|Importer||must mark all schedule 1-5 & List 1 codes|
|Manufacturer||must mark all schedule 1, 2 & List 1 codes|
|Distributor||must mark all schedule 1, drug code 2012|
|Reverse Distributor||must mark all schedule 1, drug code 2012|
|Researcher w/Sched 1||must mark schedule 1|
|Researcher w/Sched 2-5||must mark schedule 2 to be manufactured or imported
as part of research
|SCHEDULE 1 NARCOTIC & NON-NARCOTIC||CODE||BULK?|
|4-Methyl - 2,5 - Dimethoxyamphetamine (DOM, STP)||7395|
|4-Methylaminorex (cis isomer) (U4Euh, McN-422)||1590|
|Alphacetylmethadol (except LAAM)||9603|
|Marihuana / Cannabidiol||7360/7372|
|Diethyltryptamine (DET) (||7434|
|Difenoxin 1MG/25UG AtSO4 /DU (Motofen)||9167|
|Etorphine (except HCL)||9056|
|Gamma Hydroxybutyric Acid (GHB)||2010|
|Lysergic acid diethylamide (LSD)||7315|
|SCHEDULE 2 NARCOTIC & NON-NARCOTIC||CODE||BULK?|
|Amobarbital (Amytal, Tuinal)||2125|
|Amphetamine (Dexedrine, Adderall)||1100|
|Cocaine (Methyl benzoylecgonine)||9041|
|Codeine (Morphine methyl ester)||9050|
|Meperidine (Demerol, Mepergan)||9230|
|Methadone (Dolophine, Methadose)||9250|
|Methylphenidate (Concerta, Ritalin)||1724|
|Morphine (MS Contin, Roxanol)||9300|
|Oxycodone (Oxycontin, Percocet)||9143|
|Pentobarbital (bulk) (Nembutal)||2270|
|Secobarbital (Seconal, Tuinal)||2315|
|SCHEDULE 3 NARCOTIC & NON-NARCOTIC||CODE||BULK?|
|Barbituric acid derivative||2100|
|Benzphetamine (Didrex, Inapetyl)||1228|
|Buprenorphine (Buprenex, Temgesic)||9064|
|Codeine combo product (Empirin)||9804|
|Dihydrocodeine combo product (Compal)||9807|
|Dronabinol in sesame oil soft cap (Marinol)||7369|
|Gamma-Hydroxybutyric Acid preparations (Zyrem)||2012|
|Hydrocodone combo products (Lorcet, Vicodin)||9806|
|Ketamine (Ketaset, Ketalar)||7285|
|Morphine combo product||9810|
|Opium combo product (Paregoric)||9809|
|Pentobarbital suppository dosage (FP3)||2270|
|Phendimetrazine (Plegine, Bontril)||1615|
|SCHEDULE 4 NARCOTIC & NON-NARCOTIC||CODE||BULK?|
|Barbital (Veronal, Plexonal)||2145|
|Chloral Hydrate (Noctec)||2465|
|Meprobamate (Milltown, Equanil)||2820|
|Oxazepam (Serax, Serenid-D)||2835|
|Phenobarbital (Fastin, Zantryl)||2285|
|Zolpidem (Ambien, Stilnox)||2783|
|SCHEDULE 5 NARCOTIC & NON-NARCOTIC||CODE||BULK?|
|Codeine preparations (Robitussin A-C, Pediacof)||9050|
|Pyrovalerone (Centroton, Thymergix)||1485|
|LIST 1 REGULATED CHEMICALS
** ONLY manufacturers & importers may select List 1
WRITE IN ADDITIONAL CODES
You may write in additional drug codes in this section. Attach a separate sheet if needed.
TELEPHONE: HQ Call Center (800) 882-9539
WRITTEN INQUIRIES: DEA, Attn: Registration Section/ODR, P.O. Box 2639, Springfield, VA 22152-2639.
All offices are listed on web site (800, 877, and 888 are toll-free)